Addressing the Omicron Variant of SARS-CoV-2 | NEJM
Audio Interview from the New England Journal of Medicine — Addressing the Omicron Variant of SARS-CoV-2
Audio Interview from the New England Journal of Medicine — Addressing the Omicron Variant of SARS-CoV-2
Image Challenge from the New England Journal of Medicine — May 2, 2024
Repeated attempts at endotracheal intubation are associated with increased adverse events in neonates. When clinicians view the airway directly with a laryngoscope, fewer than half…
This episode examines CAR T-cell therapy’s early successes, broader promise, and emerging risks, as the FDA considers reports of occasional secondary cancers. A full transcript…
Subcutaneous administration of the monoclonal antibody L9LS protected adults against controlled Plasmodium falciparum infection in a phase 1 trial. Whether a monoclonal antibody administered subcut…
Among low-risk patients with severe, symptomatic aortic stenosis who are eligible for both transcatheter aortic-valve implantation (TAVI) and surgical aortic-valve replacement (SAVR), data are lack…
A 63-year-old woman was noted to have white-yellow rings in both eyes. On slit-lamp examination, two concentric rings were seen in each cornea.
Quick Take Video Summary from The New England Journal of Medicine — ApoA1 Infusions after Myocardial Infarction
The FDA is considering implementing a nicotine product standard, under which cigarettes could contain only very low levels of nicotine. Preparing for the tobacco industry’s…
A 72-year-old man who had emigrated from Zimbabwe 20 years previously presented with a 17-year history of swelling of the penis, scrotum, and left leg.
Plasmodium falciparum causes more than 600,000 malaria deaths annually. Whether the monoclonal antibody L9LS can protect children from P. falciparum infectio…